Your Article Summary
Boehringer Ingelheim announces record productivities for CHO cells using the BI-HEX technology platform
Boehringer Ingelheim, 11/03/09
A team of Boehringer Ingelheim scientists reports another milestone in the development of the BI–HEX technology platform. A record productivity of more than 100 picogramms per cell per day was achieved in inoculum and fed–batch cultures of BI–HEX Chinese hamster ovary cell lines expressing a therapeutic monoclonal antibody.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Expanding The Biopharmaceutical Industry's Involvement In Fighting Neglected Diseases
Health Affairs, 11/19/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09
Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09
Article Search
Sponsor


See Latest Articles


